Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

Safety and Preliminary Efficacy Study of Mesenchymal Precursor Cells (MPCs) in Subjects With Lumbar Back Pain

ClinicalTrials.gov ID: NCT01290367

Public ClinicalTrials.gov record NCT01290367. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 7, 2026, 1:54 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Prospective, Double Blind, Controlled Study Evaluating Safety and Preliminary Efficacy of a Single Injection of Adult Mesenchymal Precursor Cells (MPCs) Combined With Hyaluronan in Subjects With Chronic Discogenic Lumbar Back Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to compare two doses of immunoselected, culture-expanded, nucleated, allogeneic adult MPCs when combined with hyaluronic acid to two control intradiscal injections in subjects with chronic low back pain due to moderate Degenerative Disc Disease (DDD) at one lumbar level from L1 to S1. All investigational subjects in this study will undergo injection of either 6 million (M) or 18M cells in a hyaluronic acid carrier into the degenerated lumbar disc's nucleus pulposus. All control subjects will undergo an intradiscal control injection with either saline or hyaluronic acid only

Study identification

NCT ID
NCT01290367
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Mesoblast, Ltd.
Industry
Enrollment
100 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 31, 2011
Primary completion
Jun 30, 2013
Completion
Jun 30, 2015
Last update posted
Jun 25, 2020

2011 – 2015

United States locations

U.S. sites
13
U.S. states
9
U.S. cities
13
Facility City State ZIP Site status
Arizona Pain Specialists Scottsdale Arizona 85258
UC Davis Spine Center Sacramento California 95816
The Spine Institute Santa Monica California 90403
IPM Medical Group, Inc. Walnut Creek California 94598
Denver Spine Denver Colorado 80111
Rocky Mountain Associates in Orthopedic Medicine, P.C. Loveland Colorado 80538
Emory University School of Medicine Atlanta Georgia 30329
Carolina Neurosurgery and Spine Associates Charlotte North Carolina 28204
Central Texas Spine Institute Austin Texas 78731
Richmond Bone and Joint Clinic, Memorial Hermann Medical Group Richmond Texas 77469
Virginia Spine Research Institute, Inc. Richmond Virginia 23235
Washington Center for Pain Management Edmonds Washington 98026
The Center for Pain Relief, Inc. Charleston West Virginia 25301

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01290367, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 25, 2020 · Synced Sep 7, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01290367 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →